We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WYNN:NASDAQWynn Resorts, Limited Analysis

Data as of 2026-09-01 - not real-time

$91.28

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Wynn Resorts, Limited trades at $91.28, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Over a rolling month the price has lost 4.6%. With RSI at 30.5 the momentum picture is approaching oversold, alongside a bearish MACD signal. Price has been bracketed by support at $90.87 and resistance at $109.24.
On valuation the read is fair — an earnings multiple of 22.8, absent a reliable peer benchmark. Analyst price targets sit 45.3% above the current price. Revenue is growing at 6.9% on a 6.1% profit margin. The 1.05% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 27.5%, a beta of 0.85 and a maximum drawdown of 31.5%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

Wynn Resorts stock reflects a mix of Macau recovery and strong Las Vegas profitability, with recentUpdated Aug 4, 2026 0 LAS VEGAS, August 4, 2026 /PRNewswire/ -- Wynn Resorts, Limited NASDAQ: WYNN "Wynn Resorts" or...Wynn Resorts stock reflects a stronger Macau and Las Vegas backdrop, with 2024 results showing doubl

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 107.73
  • MACD momentum is negative
  • Maximum drawdown of 31.5%

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 107.73
  • Analyst targets imply +45.3% versus the current price
  • MACD momentum is negative

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Analyst targets imply +45.3% versus the current price
  • P/E ratio of 22.8
  • Dividend yield of 1.05%

Key Metrics & Analysis

Financial Health

Revenue Growth6.90%
Profit Margin6.05%
P/E Ratio22.8
ROA5.73%
P/B Ratio-54.9
Op. Cash Flow$1.5B
Free Cash Flow$476.2M

Technical Analysis

TrendNeutral
RSI30.5
Support$90.87
Resistance$109.24
MA 20$99.87
MA 50$98.91
MA 200$107.73
MACDBearish
VolumeStable
Fear & Greed Index92.93

Valuation

Target Price$132.58
Upside/Downside45.25%
GradeFair
TypeBlend
Dividend Yield1.05%

Risk Assessment

Beta0.85
Volatility27.53%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.